Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
The American Association for Cancer Research (AACR) is proud to announce a new collaboration with a grants program aimed at...
Margaret Foti, PhD, MD (hc), chief executive officer of the American Association for Cancer Research, has been honored with the...
Every cell in the human body contains about 300 million base pairs of double-stranded DNA that contribute to a...
For the past three years, cohorts of talented young researchers from around the world have participated in the AACR Annual...
“If our patients are diverse, why are clinical trials so white?” Vanessa Sheppard, PhD, invoked this quote from author and...
AACR on Campus – Defeating Cancer through Global Education and Training is a global outreach program that will bring...
While cancer and COVID-19 are, biologically, very different diseases, they have shaken the world in surprisingly similar ways. Nearly...
Among the studies published during the month of October in the nine AACR journals, the editors have chosen to highlight results from two clinical trials of DNA...
Guest post by Patrick Tan, MD, PhD From November 1-3, 2021, Singapore will hold its 13th Frontiers in Cancer...
Due to advances in screening and treatment, the survival rate for patients with breast cancer has increased in recent decades. However, this progress...